Akebia Therapeutics (AKBA) Other Gross PP&E Adjustments: 2016-2025
Historic Other Gross PP&E Adjustments for Akebia Therapeutics (AKBA) over the last 10 years, with Sep 2025 value amounting to -$6.4 million.
- Akebia Therapeutics' Other Gross PP&E Adjustments rose 38.93% to -$6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.8 million, marking a year-over-year increase of 42.34%. This contributed to the annual value of -$9.7 million for FY2024, which is 48.01% up from last year.
- As of Q3 2025, Akebia Therapeutics' Other Gross PP&E Adjustments stood at -$6.4 million, which was up 16.35% from -$7.6 million recorded in Q2 2025.
- Akebia Therapeutics' 5-year Other Gross PP&E Adjustments high stood at -$6.4 million for Q3 2025, and its period low was -$32.6 million during Q1 2022.
- For the 3-year period, Akebia Therapeutics' Other Gross PP&E Adjustments averaged around -$13.0 million, with its median value being -$11.8 million (2024).
- Per our database at Business Quant, Akebia Therapeutics' Other Gross PP&E Adjustments tumbled by 30.81% in 2022 and then surged by 55.78% in 2023.
- Akebia Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at -$28.6 million in 2021, then rose by 19.86% to -$22.9 million in 2022, then grew by 18.93% to -$18.6 million in 2023, then soared by 48.01% to -$9.7 million in 2024, then surged by 38.93% to -$6.4 million in 2025.
- Its last three reported values are -$6.4 million in Q3 2025, -$7.6 million for Q2 2025, and -$8.1 million during Q1 2025.